147

therapeutic
published patents

56

oncology
published patents

310

research tools

46

diagnostic
published patents

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

Applications
Therapy areas
Download
More posts

Methods for prediction and monitoring of spontaneous preterm birth

In the present invention, thanks to a prospective multicenter cohort study including 200 pregnant patients with five-serum sampling per patient, […]

Hla-deleted glomerular endothelial cells and diagnostic method

The invention relates to an engineered glomerular endothelial cell comprising areduction in expression of a human leukocyte antigen and its use in an […]

Method for quantifying ahsp protein and its use for prognosing a

The Alpha haemoglobin-stabilising protein (AHSP) is a key chaperone molecule synthesised in red blood cell (RBC) precursors. In this study, the […]

New biomarker for determining platelet age and cause of

Deamidation is usually viewed as a post-translational modification that sets an expiration date on proteins. Among apoptosis regulators of the Bcl-2 […]

Nanobody targeting von wilebrand factor a3-domain

"Inventors have isolated a single-domain antibody (designated KB-VWF-D3.1) targeting the A3-domain, the epitope of which overlaps the collagen-binding […]

Antigenic peptides for the diagnosis and treatment of type 1 diabetes

Despite the notion that human CD8+ T cells are the final mediators of autoimmune ?-cell destruction in type 1 diabetes (T1D), none of their target […]

Methods for assessing the exhaustion of hematopoietic stems cells

Engraftment of hematopoietic stems cells (HSCs) is a potentially life-saving treatment therapy for various conditions including genetic blood cell […]

Methods for predicting the survival time of patients suffering from a

The present invention relates to methods for predicting the survival time of patients suffering from a lung cancer. In particular, the present […]

Detection of ppix for use in methods for melanoma ferroptosis

Here, the inventors have developed a spectral flow cytometry assay to measure heme biosynthesis. By using this new assay on melanoma cell lines, they […]

Methods for predicting active disease in a subject suffering from

Multiple sclerosis (MS) is a neuroinflammatory disease driven by B- and T-cells. The role of follicular regulatory T cells (Tfr) in MS remains […]

More posts

You might also be interested in